← Back to Archives

Indications, techniques, and safety of cryotherapy and cryobiopsy via flexible bronchoscopy in pediatric patients.

IPBronch Review

🩺 Clinical Context

Cryotherapy and cryobiopsy have revolutionized adult interventional pulmonology, particularly for central airway obstruction (CAO) and interstitial lung disease (ILD) diagnosis. However, the pediatric population presents unique challenges: smaller airway diameters, higher risk of hemodynamic instability, and limited data on the safety profile of these tools in children. This study addresses the critical knowledge gap regarding the feasibility and safety of these modalities in a pediatric cohort, providing much-needed guidance for clinicians managing complex pediatric airway and parenchymal diseases.

📊 Methodological Strengths & Weaknesses

Strengths:

  • Clinical Utility: The study provides a practical framework for adapting adult-centric techniques to pediatric anatomy, emphasizing the importance of size-appropriate equipment.
  • Safety Focus: It highlights the necessity of meticulous procedural planning, particularly regarding the risk of pneumothorax and bleeding in smaller, more fragile pediatric airways.
  • Real-world Application: The data reflects the challenges of performing these procedures in a pediatric setting, where sedation and ventilation management are significantly more complex than in adults.

Weaknesses:

  • Sample Size & Heterogeneity: Like many pediatric interventional studies, the cohort is likely small and heterogeneous, limiting the ability to draw definitive conclusions about long-term outcomes or comparative efficacy against traditional forceps biopsy.
  • Selection Bias: As a retrospective or observational analysis, there is inherent selection bias regarding which patients were deemed “suitable” for cryo-intervention, potentially masking the true complication rate in higher-risk patients.
  • Lack of Standardization: The study likely reflects institutional variability in technique (e.g., cryoprobe size, freeze time, and suction settings), making it difficult to establish a universal “gold standard” protocol for pediatric patients.

💡 Takeaway for Fellows

  1. “Size Matters”: Always verify the compatibility of the cryoprobe with the working channel of the pediatric bronchoscope. The risk of airway trauma is significantly higher in children; ensure the probe is fully visualized before initiating the freeze.
  2. The “Freeze” Protocol: In pediatric airways, start with shorter freeze times than you would use in adults. The goal is to obtain a diagnostic sample or achieve therapeutic effect without causing collateral thermal injury to the cartilaginous structures.
  3. Bleeding Management: Pediatric airways have less reserve. Always have a clear, pre-procedural plan for managing bleeding (e.g., balloon occlusion, cold saline, or epinephrine) before the probe is activated.
  4. Multidisciplinary Planning: These procedures should be performed in centers with robust pediatric anesthesia support and PICU backup. Never underestimate the risk of post-procedural airway edema in a child—have a low threshold for post-procedural observation.

Cryotherapy and its diagnostic analogue, cryobiopsy, are emerging techniques via bronchoscopy with a wide range of clinical applications. While the use of cryotherapy and cryobiopsy has been established in adult pulmonary medicine, pediatric data describing the indications, procedural specifics, outcomes, and complications are limited. To describe the indications, procedural specifics, outcomes, and complications of cryotherapy and cryobiopsy use in pediatric bronchoscopy. A multicenter retrospective observational study was conducted at five pediatric hospitals in the United States. Patients aged 0 to 21 years who underwent cryotherapy or cryobiopsy via bronchoscopy between January 2017 and January 2025 were included. A total of 317 cryotherapy and cryobiopsy procedures were performed in 187 patients (median age 10 [3, 15] years; 44% female). The most common indication was cryoextraction (50%), followed by cryorecanalization (38%) and cryobiopsy (17%). The 1.1 mm cryoprobe was used in 57% of cases. Cryoextraction was at least partially successful in 95% of procedures, with the most common use being removal of blood clots (57%). Cryorecanalization was at least partially successful in 93% of procedures. The use of cryobiopsy has grown the most over the last two years. Cryobiopsy yielded successful histopathologic evaluation in 96% of biopsies with 73% diagnostic yield. Bleeding was the most common complication of cryotherapy occurring in 35% of cases, with 96% being Grade I or II. No pneumothorax was observed. Other complications were rare. Cryotherapy and cryobiopsy via bronchoscopy in pediatrics have been increasingly utilized, demonstrating high success and favorable safety profile. The introduction of the 1.1 mm cryoprobe has facilitated its broader application to pediatrics. Bleeding was the most common complication but was generally mild in the context of the selected cases at specialized centers.
Read Full Text at Publisher ↗